ALC Stock Overview
Alcidion Group Limited, together with its subsidiaries, engages in the development and licensing of healthcare software products in Australia, New Zealand, and the United Kingdom.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Alcidion Group Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.054 |
| 52 Week High | AU$0.14 |
| 52 Week Low | AU$0.04 |
| Beta | 1.31 |
| 1 Month Change | 8.00% |
| 3 Month Change | -5.26% |
| 1 Year Change | -43.75% |
| 3 Year Change | -85.41% |
| 5 Year Change | -46.00% |
| Change since IPO | -16.92% |
Recent News & Updates
Recent updates
Shareholder Returns
| ALC | AU Healthcare Services | AU Market | |
|---|---|---|---|
| 7D | 17.4% | 3.7% | -0.3% |
| 1Y | -43.8% | 64.9% | 6.1% |
Return vs Industry: ALC underperformed the Australian Healthcare Services industry which returned 67.3% over the past year.
Return vs Market: ALC underperformed the Australian Market which returned 4.9% over the past year.
Price Volatility
| ALC volatility | |
|---|---|
| ALC Average Weekly Movement | 9.4% |
| Healthcare Services Industry Average Movement | 7.9% |
| Market Average Movement | 9.0% |
| 10% most volatile stocks in AU Market | 17.7% |
| 10% least volatile stocks in AU Market | 3.5% |
Stable Share Price: ALC has not had significant price volatility in the past 3 months.
Volatility Over Time: ALC's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 191 | Kate Quirke | www.alcidion.com |
Alcidion Group Limited, together with its subsidiaries, engages in the development and licensing of healthcare software products in Australia, New Zealand, and the United Kingdom. The company offers Miya Precision, a consolidated fast healthcare interoperability resource (FHIR) based platform to deliver smart healthcare; Smartpage, a smartphone and web-based system for hospital communication and task management to address the requirements of clinical and non-clinical users; Patientrack, a real-time patient monitoring and risk screening solution; Silverlink, a patient administration system; and ExtraMed, a clinical and patient flow management software. It also provides product implementation, product support and maintenance, systems integration, and data analysis services.
Alcidion Group Limited Fundamentals Summary
| ALC fundamental statistics | |
|---|---|
| Market cap | AU$72.49m |
| Earnings (TTM) | -AU$5.11m |
| Revenue (TTM) | AU$40.48m |
1.8x
P/S Ratio-14.2x
P/E RatioIs ALC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ALC income statement (TTM) | |
|---|---|
| Revenue | AU$40.48m |
| Cost of Revenue | AU$5.30m |
| Gross Profit | AU$35.17m |
| Other Expenses | AU$40.28m |
| Earnings | -AU$5.11m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0038 |
| Gross Margin | 86.90% |
| Net Profit Margin | -12.63% |
| Debt/Equity Ratio | 0% |
How did ALC perform over the long term?
See historical performance and comparison